Glenmark is the first company in India to have received the regulator’s approval for 400 mg dosage form
Increased strength of FabiFlu® yet another milestone effort by Glenmark’s in-house R&D
Patients can now opt for a more relaxed dosage regimen when compared to 200 mg tablet and now need to take half the number of pills due to the introduction of 400 mg
Glenmark remains the only company in India to successfully complete an randomized, controlled, open-labelled, multi-center Phase 3 clinical trial on Indian patients with mild to moderate Covid-19
India; August, 2020:Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, today announced that it will introduce a 400 mg version of oral antiviral FabiFlu®, for the treatment of mild to moderate COVID-19 in India. The higher strength will improve patient compliance and experience, by effectively reducing the number of tablets that patients require per day.
A higher pill burden has been associated with lower adherence to therapy, the latter affecting viral suppression and overall treatment outcomes. Also reducing the pill burden has been a demand from doctors and patients to enable adherence. The 200 mg dosage of FabiFlu® required patients to take 18 tablets on Day 1 (nine in the morning and nine in the evening), followed by 8 tablets each day thereafter for a maximum of 14 days. With the new 400 mg version, patients will now have a more relaxed dosage regimen, with 9 tablets required on Day 1( 4.5 in the morning and 4.5 in the evening), and thereafter 2 tablets twice a day from Day 2 till end of the course.
Explaining the significance of this development, Dr. Monika Tandon, Vice President & Head, Clinical Development, Global Specialty/Branded Portfolio, Glenmark Pharmaceuticals Ltd., said, “Being the first company to launch Favipiravir in India, we continue to innovate and seek new treatment options for Covid-19 patients. Introducing this higher strength of FabiFlu® is in line with these efforts to ensure a smoother experience for patients, by reducing their daily pill burden.”
“The 200 mg dosage of FabiFlu® was developed in line with global formulations of the drug Favipiravir, which had similar strength. The 400 mg version is a result of Glenmark’s own R&D efforts to improve treatment experience for patients in India,” she added.
Empower your team. Lead the industry
Get a subscription to a library of online courses and digital learning tools for your organization with EasyShiksha
Yes, all internships offered by EasyShiksha are completely free of charge.
Q.How can I apply for an internship with EasyShiksha?
You can apply for an internship with EasyShiksha by visiting our website and browsing through the available internship opportunities. Once you find a suitable internship, simply follow the application instructions provided.
Q.What types of internships are available through EasyShiksha?
EasyShiksha offers a wide range of internships across various industries and disciplines, including but not limited to technology, business, marketing, healthcare, and more. We continuously update our internship offerings to provide diverse opportunities for our users.
Q.Will I receive a certificate upon completing an internship?
Yes, upon successful completion of an internship with EasyShiksha, you will receive a certificate recognizing your participation and achievements during the internship period.
Q.Are EasyShiksha's internship certificates recognized by universities and employers?
Yes, EasyShiksha's internship certificates are recognized and valued by universities, colleges, and employers worldwide. They serve as a testament to your skills, knowledge, and experience gained through our internship programs.
Q.Is the download of certificates free or paid?
While access to internships and all courses on EasyShiksha is free for users lifetime, there is a nominal operational cost associated with downloading certificates. This fee covers the administrative expenses involved in processing and issuing the certificates.
Q.When can I start the course?
Anyone can choose a preferred course and start immediately without any delay.
Q.What are the course and session timings?
As this is a purely online course program, you can choose to learn at any time of the day and for as much time as you want. Though we follow a well-established structure and schedule, we recommend a routine for you as well. But it finally depends on you, as you have to learn.
Q.What will happen when my course is over?
If you have completed the course, you would be able to have lifetime access to it for future reference too.
Q.Can I download the notes and study material?
Yes, you can access and download the content of the course for the duration. And even have lifetime access to it for any further reference.
Q. What software/tools would be needed for the course and how can I get them?
All the software/tools that you need for the course would be shared with you during the training as and when you need them.
I’m unable to make a payment. What to do now?
You can try to make the payment through a different card or account (maybe a friend or family). If the problem persists, email us at info@easyshiksha.com
Q. Do I get the certificate in a hard copy?
No, only a soft copy of the certificate will be awarded, which can be downloaded and printed, if required.
Q. The payment got deducted, but the updated transaction status is showing “failed”. What to do now?
Due to some technical faults, this can happen. In such a case the amount deducted will be transferred to the bank account in the next 7-10 working days. Normally the bank takes this much time to credit the amount back into your account.
Q. The payment was successful but it still shows ‘Buy Now’ or not showing any videos on my dashboard? What should I do?
At times, there may be a slight delay in your payment reflecting on your EasyShiksha dashboard. However, if the problem is taking longer than 30 minutes, please let us know by writing to us at info@easyshiksha.com from your registered email id, and attach the screenshot of the payment receipt or transaction history. Soon after verification from the backend, we will update the payment status.
Q. What is the refund policy?
If you have enrolled, and are facing any technical problem then you can request a refund. But once the certificate has been generated, we shall not refund that..
Q.Can I just enrol in a single course?
Yes! You surely can. To begin this, just click the course of your interest and fill in the details to enrol. You are ready to learn, once the payment is made. For the same, you earn a certificate too.
My questions are not listed above. I need further help.
Please contact us at: info@easyshiksha.com
Glenmark has also commenced a Post Marketing Surveillance (PMS) study on FabiFlu® to closely monitor the efficacy and safety of the drug in a large pool of patients prescribed with the oral antiviralFavipiravir, as part of an open label, multicenter, single arm study.Glenmark is also conducting another Phase 3 clinical trial to evaluate the efficacy of two antivirals drugs Favipiravir and Umifenovir as a combination therapy in moderate hospitalized adult COVID-19 patients in India. The combination study which is called the FAITH trial is looking to enrol 158 hospitalized patients of moderate COVID-19 in India. Early treatment with combination therapy will be evaluated for safety and efficacy as it is emerging as an effective approach in shortening duration of virus shedding, facilitating early clinical cure and discharge of patients.
